Cargando…
Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses
There are currently no drugs available for the treatment of enterovirus (EV)-induced acute and chronic diseases such as the common cold, meningitis, encephalitis, pneumonia, and myocarditis with or without consecutive dilated cardiomyopathy. Here, we report the discovery and characterization of pyra...
Autores principales: | Makarov, Vadim A, Braun, Heike, Richter, Martina, Riabova, Olga B, Kirchmair, Johannes, Kazakova, Elena S, Seidel, Nora, Wutzler, Peter, Schmidtke, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600222/ https://www.ncbi.nlm.nih.gov/pubmed/26260222 http://dx.doi.org/10.1002/cmdc.201500304 |
Ejemplares similares
-
A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses
por: Abdelnabi, Rana, et al.
Publicado: (2019) -
Hemagglutinin 222D/G Polymorphism Facilitates Fast Intra-Host Evolution of Pandemic (H1N1) 2009 Influenza A Viruses
por: Seidel, Nora, et al.
Publicado: (2014) -
Computer-Guided
Approach to Access the Anti-influenza
Activity of Licorice Constituents
por: Grienke, Ulrike, et al.
Publicado: (2013) -
Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae
por: Grienke, Ulrike, et al.
Publicado: (2016) -
Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
por: Weitensteiner, Sabine B., et al.
Publicado: (2013)